A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
At 52 weeks, evolocumab added to diet alone, to low-dose atorvastatin, or to high-dose atorvastatin with or without ezetimibe significantly reduced LDL cholesterol levels in pat...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 697
- Institution
- Charles University
External Links
Identifiers
- ORCID
- 0000-0002-2541-5179
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.